{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:59:29Z","timestamp":1783749569990,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euros.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:26:01Z","timestamp":1775316361000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation \u2013 Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010\u20132023"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7934-2449","authenticated-orcid":false,"given":"Jan","family":"Chandra Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"J\u00e4derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.03.015_b0005","unstructured":"Cornford P TD, van den Bergh R.C.N., Briers E., Eberli D., De Meerleer G., De Santis M. EAU guidelines. Edn. presented at the EAU Annual Congress Paris; 2024. EAU Guidelines Office. Arnhem, The Netherlands; Published 2024. Accessed."},{"key":"10.1016\/j.euros.2026.03.015_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","article-title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003\u20132011","volume":"63","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0015","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2026.03.015_b0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50\u201369 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gr\u00f6nberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2026.03.015_b0025","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.03.015_b0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (Promis): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2026.03.015_b0035","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.03.015_b0040","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.03.015_b0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euros.2026.03.015_b0050","unstructured":"Mottet N, PC, van den Bergh RCN, Briers E, et al. Wiegel. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023; 2023."},{"key":"10.1016\/j.euros.2026.03.015_b0055","unstructured":"Nationellt v\u00e5rdprogram. Prostatacancer. https:\/\/kunskapsbanken.cancercentrum.se\/globalassets\/cancerdiagnoser\/prostatacancer\/vardprogram\/nvp-prostatacancer2.pdf."},{"key":"10.1016\/j.euros.2026.03.015_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euros.2026.03.015_b0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.juro.2014.07.098","article-title":"Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance","volume":"193","author":"Radtke","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2026.03.015_b0085","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000642","article-title":"International Society of Urological Pathology (ISUP) grading of prostate cancer","volume":"40","author":"Egevad","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2026.03.015_b0090","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2026.03.015_b0095","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2026.03.015_b0100","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euros.2026.03.015_b0105","unstructured":"National Cancer Institute. Cancer trends progress report. 2024. https:\/\/progressreport.cancer.gov\/."},{"key":"10.1016\/j.euros.2026.03.015_b0110","doi-asserted-by":"crossref","first-page":"23503","DOI":"10.1038\/s41598-021-02696-z","article-title":"Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial","volume":"11","author":"Tiedje","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2026.03.015_b0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077738","article-title":"Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study","volume":"386","author":"Vaccarella","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.03.015_b0120","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.3399\/bjgp20X713957","article-title":"Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998\u20132017","volume":"71","author":"Clift","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.euros.2026.03.015_b0125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamainternmed.2017.0340","article-title":"Recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States","volume":"177","author":"Fedewa","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.euros.2026.03.015_b0130","unstructured":"European Union. Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=oj:JOC_2022_473_R_0001."},{"key":"10.1016\/j.euros.2026.03.015_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-12-26","article-title":"Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen","volume":"12","author":"Vickers","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.euros.2026.03.015_b0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.eururo.2023.03.016","volume":"84","author":"de Vos","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2024.3841","article-title":"Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial","volume":"331","author":"Auvinen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.03.015_b0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.11.013","article-title":"Population-based organised prostate cancer testing: results from the first invitation of 50-year-old men","volume":"85","author":"Bratt","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","article-title":"Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway","volume":"20","author":"Barrett","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euros.2026.03.015_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2025.01.004","article-title":"Impact of prebiopsy multiparametric magnetic resonance imaging on prostate cancer detection in Switzerland","volume":"73","author":"Scherer","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.03.015_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.euros.2023.03.010","article-title":"Systematic review and narrative synthesis of economic evaluations of prostate cancer diagnostic pathways incorporating prebiopsy magnetic resonance imaging","volume":"52","author":"Merriel","year":"2023","journal-title":"Eur Urol Open Sci"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:46:14Z","timestamp":1779306374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"alternative-id":["S2666168326000601"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.015","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation \u2013 Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010\u20132023","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}